Outcome of prenatally diagnosed isolated congenital complete atrioventricular block treated with transplacental betamethasone or ritodrine therapy

Pediatric Cardiology

Volumn 30, Issue 1, 2009, Pages 35-40

  Hayashi, Taiyu ^a   Kaneko, Masahide ^a   Kim, Ki Sung ^a   Eryu, Yoshihiko ^a   Shindo, Takahiro ^a   Isoda, Takayoshi ^a   Murashima, Atsuko ^a   Ito, Yushi ^a   Sago, Haruhiko ^a  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Anti SSA Ro antibody; Atrioventricular block; Betamethasone; Congenial; Fetal hydrops

Indexed keywords

BETAMETHASONE; RITODRINE; RO ANTIBODY;

APPETITE; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMPLETE HEART BLOCK; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HEART FUNCTION; HUMAN; INFANT; INSOMNIA; MALE; MOOD DISORDER; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; SIDE EFFECT; TREATMENT OUTCOME;

ADRENERGIC BETA-AGONISTS; ATRIOVENTRICULAR BLOCK; BETAMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROPS FETALIS; INFANT, NEWBORN; MALE; PLACENTA; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; RITODRINE; TREATMENT OUTCOME;

EID: 58649092375     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-008-9273-5     Document Type: Article

References (21)

1. CS Barclay MAH French LD Ross RJ Sokol 1987 Successful pregnancy following steroid therapy and plasma exchange in a woman with anti-Ro (SS-A) antibodies: case report Br J Obstet Gynaecol 94 369 371
2. A Brucato M Frassi F Franceschini 2001 Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women Arthritis Rheum 44 1832 1835
3. A Brucato MG Astori R Cimaz 2006 Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero Ann Rheum Dis 65 1422 1426
4. JP Buyon R Hiebert J Copel 1998 Autoimmune-associated congenital heart block: demographics, mortality, morbidity, and recurrence rates obtained from a national neonatal lupus registry J Am Coll Cardiol 31 1658 1666
5. RJ Carpenter JF Strasburger A Garson 1986 Fetal ventricular pacing for hydrops secondary to complete atrioventricular block J Am Coll Cardiol 8 1434 1436
6. N Costedoat-Chalumeau Z Amoura DLT Hong 2003 Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block Ann Rheum Dis 62 1010 1012
7. N Costedoat-Chalumeau Z Amoura JM Lupoglazoff 2004 Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group Arthritis Rheum 50 3187 3194
8. E Deloof H Devlieger R Van Hoestenberghe K Vandenberghe W Daenen M Gewllig 1996 Management with a staged approach of the premature hydropic fetus due to complete congenital heart block Eur J Pediatr 156 521 523
9. DM Friedman MY Kim JA Copel 2008 Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR interval and dexamethasone evaluation (PRIDE) prospective study Circulation 117 485 493
10. G Gladman ED Silverman Yuk-Law 2002 Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies Am J Perinatol 19 73 80
11. AMM Grove LD Allan E Rosenthal 1996 Outcome of isolated congenital complete heart block diagnosed in utero Heart 75 190 194
12. LK Hornberger DJ Sahn 2007 Rhythm abnormalities of the fetus Heart 93 1294 1300
13. ET Jaeggi RM Hamilton ED Silverman 2002 Outcome of children with fetal, neonatal, or childhood diagnosis of isolated congenital atrioventricular block J Am Coll Cardiol 39 130 137
14. ET Jaeggi JC Fouron ED Silverman 2004 Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease Circulation 110 1542 1548
15. K Kurosaki A Miyazaki K Watanabe S Echigo 2008 Long-term outcome of isolated congenital complete atrioventricular block pacing since neonatal period: experience at a single Japanese institution Circ J 72 81 87
16. BH Lee BJ Stoll SA McDonald RD Higgins 2008 Neurodevelopmental outcomes of extremely low-birth-weight infants exposed prenatally to dexamethasone versus betamethasone Pediatrics 121 289 296
17. Y Maeno W Himeno A Saito 2005 Clinical course of fetal congenital atrioventricular block in the Japanese population: a multicentre experience Heart 91 1075 1079
18. M Michaelsson MA Engle 1972 Congenital complete heart block: an international study of the natural history story Clin Cardiol 4 86 101
19. S Saleeb J Copel D Friedman JP Buyon 1999 Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus Arthritis Rheum 42 2335 2345
20. E Villain N Coastedoat-Chalumeau E Marijon Y Boudjemline JC Piette D Bonnet 2006 Presentation and prognosis of complete atrioventricular block in childhood, according to maternal antibody status J Am Coll Cardiol 48 1682 1687
21. SN Weindling JP Saul JK Triedman 1994 Staged pacing therapy for congenital complete heart block in premature infants Am J Cardiol 74 412 413